Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients
- 6 December 2017
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 94 (2) , 116-124
Abstract
A large cohort of hepatocellular carcinoma (HCC) patients from several collaborating Turkish institutions were examined for the tumor parameters of maximum diameter (MTD), portal vein thrombosis (PVT), and α-fetoprotein (AFP) levels. A relationship was found between MTD and blood platelet levels. Patients with large ≥5 cm tumors who had normal platelet levels had significantly larger tumors, higher percent of PVT, and significantly lower blood total bilirubin and liver cirrhosis than similar ≥5 cm tumor patients having thrombocytopenia. A comparison of patients with and without PVT showed significantly larger tumors, greater multifocality, blood AFP, and C-reactive protein levels, and, interestingly, lower HDL levels in the patients with PVT. Fifty-eight percent of the total cohort had AFP levels ≤100 IU/mL (and 42.1% had values ≤20 IU/mL). These patients had significantly smaller tumors, less tumor multifocality and percent PVT, lower total bilirubin, and less cirrhosis. There was considerable geographic heterogeneity within Turkey in the patterns of HCC presentation, with areas of higher and lower hepatitis B virus, hepatitis D virus, cirrhosis, and tumor aggressiveness parameters. Turkish patients thus have distinct patterns of presentation, but the biological relationships between MTD and both platelets and bilirubin levels are similar to the relationships that have been reported in other ethnic patient groups.Keywords
This publication has 14 references indexed in Scilit:
- The prognostic utility of baseline alpha‐fetoprotein for hepatocellular carcinoma patientsJournal of Surgical Oncology, 2017
- Validation and ranking of seven staging systems of hepatocellular carcinomaOncology Letters, 2017
- A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme LevelsOncology, 2016
- Ongoing challenges in the diagnosis of hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology, 2015
- Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinomaLangenbeck's Archives of Surgery, 2015
- Surveillance and Diagnostic Algorithm for Hepatocellular Carcinoma Proposed by the Liver Cancer Study Group of Japan: 2014 UpdateOncology, 2014
- HCC and its microenvironment.Hepatogastroenterology, 2013
- Thrombocytopenia in Relation to Tumor Size in Patients with Hepatocellular CarcinomaOncology, 2012
- Epidemiology, risk factors and surveillance of hepatocellular carcinoma.2010
- Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high‐risk for hepatocellular carcinomaCancer, 2006